Jinxin Fertility launches China’s first doctor-facing IVF clinical AI agent
The assisted reproduction services provider is piloting the new agent at a Sichuan hospital to support doctors across IVF workflows By Teri Yu Leading assisted reproduction services provider Jinxin Fertility…
BRIEF: Jinxin Fertility’s business improves in fourth quarter
Fertility services provider Jinxin Fertility Group Ltd. (1951.HK) provided 7,004 in vitro fertilization (IVF) treatments to its customers in last year’s fourth quarter, up 12% from a year earlier, according…
RELATED ARTICLES
-
Jinxin returns to the black on U.S. recovery, focus on high-end clients
1951.HK
- China’s AI regulation debate enters the agent era
- Good Doctor Cloud Healthcare’s ailing margins belie uninspired new listing
- AI in China’s medical aesthetics sector: From non-core services to clinical device integration
- Yidu Tech swings to profit as AI healthcare edges toward viability
- Building AI playmates: How multi-agent systems are bringing toys to life
- The next Manus? Deepexi navigates difficult AI agent market
